ArticleFrontiers in neurology2025
Mediation analysis for integrating motor symptoms of Parkinson's disease, cognitive function, and gait characteristics.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing motor-cognitive associations in Parkinson's disease using digital assessments.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In Parkinson's disease (PD) patients, the severity of motor symptoms is closely related to the degree of gait disorder and cognitive impairment; notably, the latter also exhibits a significant correlation with gait disorder. Evidently, there exists a complex relationship between motor symptoms, cognitive function, and gait characteristics. Methods: This study aims to conduct an in-depth analysis of the relationships among MDS-UPDRS III score, MoCA score, and gait parameters by constructing a mediation model. Results: We found that a higher MDS-UPDRS III score was associated with a smaller plantar dorsiflexion angle, slower velocity, and worse swing phase symmetry, and these associations were not mediated by the MoCA score. Age was a confounder in the relationship between MDS-UPDRS III score, MoCA, and velocity. A higher MDS-UPDRS III score was associated with shorter stride length, and this association was partially mediated by the MoCA score. Conclusion: The results indicated that, when analyzing plantar dorsiflexion angle and swing phase symmetry in PD patients, the influence of motor symptoms was dominant; when analyzing stride length, motor symptoms and cognitive function need to be considered simultaneously; when analyzing velocity, the influence of motor symptoms and age should be focused on.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.